Stablepharma Limited

📍 Bath, United Kingdom🗓 Founded 2012👥 26 employees💰 Last funded Jan 2023
Stablepharma Ltd is an innovative biopharmaceutical company developing a pipeline of fridge-free vaccine and pharmaceutical products. Stablepharma was founded with a simple purpose; to use its novel technology to dramatically improve health outcomes for those adults and children most at risk of death and disability caused by vaccine preventable diseases. StablevaX is an adaptable fridge-free technology which offers a greatly extended shelf-life, reduces vaccine wastage and CO2 emissions of the global cold-chain. The WHO estimate that approximately 50% of all vaccines manufactured are wasted due to failures in the global cold chain (distribution and storage of vaccines). Stablepharma aims to ensure that a proportion of vital vaccines and pharmaceutical products can be removed from the refrigerated cold chain and stored for months or even years at room temperature. Stablepharma is developing the worlds first fridge-free vaccine, SPVX02 for Tetanus diphtheria, a pharmaceutical product for the prevention of Tetanus and Diphtheria.
7
Total investors
0
Early stage
0
Mid stage
6
Late stage
2012
Founded
Investor geography3 countries
United Kingdom
4
Australia
2
Spain
1
Investor activity2019–2023 · investors recorded per year
20192202012022320231
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Stablepharma Limited?
Stablepharma Limited has 7 investors on record on gritt.io and 6 late-stage investors.
When did Stablepharma Limited last raise funding?
The most recent investment in Stablepharma Limited recorded on gritt.io was in January 2023.
When was Stablepharma Limited founded?
Stablepharma Limited was founded in 2012.
What industry is Stablepharma Limited in?
Stablepharma Limited operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Stablepharma Limited based?
Stablepharma Limited is headquartered in Bath, United Kingdom.